Improving Health Insurance Experiences for Adolescent and Young Adult Cancer Patients

NCT04448678 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 86

Last updated 2024-01-05

Study results available
· View outcomes & findings →

Summary

This is a test of an existing health insurance education program (HIEP) in adolescent and young adult (AYA) individuals (aged 18-39) diagnosed with cancer. The study will evaluate whether the HIEP delivered by patient navigators improves participants' health insurance and cost-related literacy compared to usual navigation care, which does not include education on insurance and medical costs. The study team hypothesizes that: The HIEP will improve participants' health insurance and cost-related literacy compared to usual navigation care. Specifically, that participants in the intervention arm will report greater 1) health insurance and cost literacy, including confidence with provider communication about costs, 2) familiarity with ACA policies, and 3) improvement in financial distress related to medical costs. Participants will fill out a survey upon enrollment and a follow up survey 3 months after meeting with a patient navigator where they may or may not receive the HIEP.

Conditions

  • Adolescent
  • Young Adult
  • Cancer

Interventions

BEHAVIORAL

Health Insurance Education Program (HIEP)

\[See arm/group descriptions\]

OTHER

Usual Care

\[See arm/group descriptions\]

Sponsors & Collaborators

  • Intermountain Health Care, Inc.

    collaborator OTHER
  • Massachusetts General Hospital

    collaborator OTHER
  • National Institutes of Health (NIH)

    collaborator NIH
  • National Cancer Institute (NCI)

    collaborator NIH
  • University of Utah

    lead OTHER

Principal Investigators

  • Anne C Kirchhoff, PhD, MPH · University of Utah Department of Pediatrics

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-21
Primary Completion
2022-09-20
Completion
2022-09-20

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04448678 on ClinicalTrials.gov